Showing results (291-300 of 946) with videos related to
Sort By:
Pageof 95
Novartis Foundation Symposium|February 9, 1999
The apraxias are higher-order defects of sensorimotor integrationC D MarsdenClinical Neuropharmacology|January 1, 1994
Problems with long-term levodopa therapy for Parkinson's diseaseC D MarsdenBiochemical Pharmacology|July 12, 1996
Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineK S McNaught, U Thull, P A Carrupt, et al.Biochemical Pharmacology|November 27, 1995
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)K S McNaught, U Thull, P A Carrupt, et al.Journal of Neurochemistry|November 1, 1986
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmosetP Jenner, H Taquet, A Mauborgne, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Function of the basal ganglia as revealed by cognitive and motor disorders in Parkinson's diseaseC D MarsdenDrugs|March 4, 1998
Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopaC D MarsdenPageof 95